Skip to content

Transcutaneous Auricular Vagus Nerve Stimulation for Postoperative Pain Management After Hip Arthroplasty in Elderly Patients: A Randomized Controlled Trial

Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation for Postoperative Pain Relief After Hip Arthroplasty in Elderly Patients: A Double-Blind, Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099856
Enrollment
Unknown
Registered
2025-03-31
Start date
2025-08-25
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Each year, approximately 4.5 million people worldwide are disabled by hip fractures, a number expected to rise to 21 million annually over the next 40 years. Hip fractures are a leading cause of disability globally, with healthcare costs in the U.S. projected to reach $9.8 billion by 2040, and $650 million in Canada. As three-quarters of the global population live in Asia, the region is expected t

Interventions

Stimulation group:Transcutaneous Auricular Vagus Nerve Stimulation
Sham stimulation group:Sham stimulation group

Sponsors

Xiaoshan Hangzhou Xiaoshan Orthopaedics TCM Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Age between 65 and 85 years; 2.Patients diagnosed with hip fracture who seek treatment at this hospital and are scheduled for hip arthroplasty under general anesthesia; 3. Voluntarily participate in the study and sign the informed consent form; 4.American Society of Anesthesiologists (ASA) physical status classification of 1-3; 5.Able to understand the study process and the use of various assessment scales, and can effectively communicate with the researchers.

Exclusion criteria

Exclusion criteria: 1.Patients with treatable arrhythmias; 2.Patients with neuromuscular diseases or left-sided auricular dermatitis; 3.History of substance abuse, including opioids; 4.Patients unable to cooperate with assessments; 5.Patients who have experienced seizures or recurrent syncope in the past 5 years; 6.History of transient ischemic attack or cerebrovascular accident; 7.Patients who have received vagus nerve stimulation or acupuncture treatment within the last month before the study; 8.Patients currently participating in other clinical trials; 9.Vulnerable populations, including individuals with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, and illiterate individuals.

Design outcomes

Primary

MeasureTime frame
Cumulative fentanyl consumption over the first 24 hours postoperatively;

Secondary

MeasureTime frame
Postoperative opioid consumption and pain scores.;Postoperative recovery quality;Postoperative sleep quality;

Countries

China

Contacts

Public ContactHan Qiuwan

Xiaoshan Hangzhou Xiaoshan Orthopaedics TCM Hospital

Hanqiuwan0326@163.com+86 15267057515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026